Clinical Trials
96
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (78 trials with phase data)• Click on a phase to view related trials
Perceptual Evaluation and Rehabilitation System Development for Congenital Hearing Loss
- Conditions
- Gene TherapyCongenital Hearing LossSpeech PerceptionRehabilitationReliability and Validity
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Eye & ENT Hospital of Fudan University
- Target Recruit Count
- 210
- Registration Number
- NCT07024524
- Locations
- 🇨🇳
Eye & ENT Hospital of Fudan University, Shanghai, China
Study on the Surgical Strategy of Corneal Endothelial Protection for Hard Nuclear Cataract Patients
- Conditions
- Hard Nuclear CataractPhacoemulsification Cataract SurgeryEndothelial Cell Density LossCentral Corneal Thickness
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Eye & ENT Hospital of Fudan University
- Target Recruit Count
- 207
- Registration Number
- NCT06991374
- Locations
- 🇨🇳
Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
- Conditions
- RetinoblastomaRetinoblastoma, Recurrent
- Interventions
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Eye & ENT Hospital of Fudan University
- Target Recruit Count
- 10
- Registration Number
- NCT06972602
- Locations
- 🇨🇳
Fudan Eye & ENT Hospital, Shanghai, China
Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With Cataracts
- Conditions
- CataractFuchs Endothelial Corneal Dystrophy
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Eye & ENT Hospital of Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT06966167
- Locations
- 🇨🇳
Eye and ENT hospital of Fudan University, Shanghai, Shanghai, China
CG-101 Eye Drops in the Treatment of Dry Eye Syndrome
- Conditions
- Dry Eye
- Interventions
- Drug: CG101 high dose + artificial tearDrug: placebo + artificial tearDrug: CG101 low dose + artificial tear
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-01-27
- Lead Sponsor
- Eye & ENT Hospital of Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT06792903
- Locations
- 🇨🇳
Eye & ENT hospital of Fudan University, Shanghai, Shanghai, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next
News
GenEditBio Doses First Patient in World's First In Vivo CRISPR Trial for TGFBI Corneal Dystrophy
GenEditBio has dosed the first patient in a groundbreaking investigator-initiated trial of GEB-101, marking the world's first clinical study of an in vivo CRISPR-Cas ribonucleoprotein-based genome editing therapy for TGFBI corneal dystrophy.
Bilateral Gene Therapy Restores Hearing in Both Ears for Children with Inherited Deafness
Five children with DFNB9 inherited deafness gained hearing in both ears after receiving bilateral gene therapy targeting OTOF gene mutations in a world-first clinical trial.